[ARWR] QoQ Quarter Result on 31-Mar-2013 [#Q2]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
09-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q2]
Profit Trend
QoQ- -46.47%
YoY- -26.67%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 44 44 44 44 159 44 48 -5.62%
PBT -10,686 -13,805 -6,178 -6,940 -4,781 -5,601 -8,240 18.86%
Tax -57,420 354 -248,228 -70 -166,550 -22,110,563 -8,239,737 -96.31%
NP -10,628 -13,692 -6,079 -6,758 -4,614 -5,314 -7,992 20.86%
Tax Rate - - - - - - - -
Total Cost 10,672 13,736 6,123 6,802 4,773 5,357 8,039 20.72%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin -24,293.28 -31,296.42 -13,894.88 -15,446.71 -2,901.69 -12,145.56 -16,677.82 28.41%
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
EPS -0.28 -0.36 -0.23 -0.41 -0.33 -0.38 -0.71 -46.13%
EPS Diluted -0.28 -0.36 -0.23 -0.41 -0.33 -0.38 -0.71 -46.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.